BlinkBio, Inc.: BlinkBio has innovated Tunable Drug Conjugates (TDCs), a new generation of Drug Conjugate therapies designed to improve on the safety and efficacy of contemporary Antibody Drug Conjugates (ADCs) – an important class of anti-cancer medicines which are used to directly target the delivery of toxins to tumors
Alexandria Innovation Center
555 Heritage Drive, Suite 165
Jupiter, FL 33458
United States

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.